In Anbetracht der steigenden Prävalenz von Übergewicht und Adipositas in Deutschland
– und auch weltweit – erhöht sich dementsprechend die Zahl der Patient*innen mit adipositasassoziierten
Komorbiditäten [1]
[2]. Eine Kenntnis dieser Folgeerkrankungen ist deshalb wesentlich, um gezielt nach
ihnen zu suchen, sie zu behandeln und dadurch die Patientenversorgung und letztendlich
die Morbidität und Mortalität der Patient*innen mit Adipositas zu verbessern.
Abstract
The prevalence of obesity has increased worldwide. For Germany, according to the “Study
on Adult Health in Germany” (DEGS1) of the Robert Koch Institute from the years 2008–2011,
the prevalence of a BMI ≥25 kg/m² was 67,1% for men and 53,0% for women, whereby the
proportion of obesity, i.e. a BMI ≥30 kg/m² is 23, 3% for men and 23,9% for women.
Compared to 1998, the prevalence of obesity in the same group was 18, 8% for men and
21,7% for women. Because of the increasing prevalence of overweight and obesity, the
number of patients with obesity-associated comorbidities is correspondingly increasing.
There is a close association between obesity and an increased risk of metabolic diseases,
cardiovascular diseases, but also musculoskeletal diseases, some types of cancer and
mental comorbidities. In addition, obesity might also lead to restrictions in activities
of daily living, reduced quality of life, unemployment and early retirement. A knowledge
of obesity-associated sequelae is therefore essential in order to specifically look
for them, treat them and thereby improve patient care and ultimately morbidity and
mortality of patients with obesity.
Schlüsselwörter
Adipositas - metabolisches Syndrom - kardiovaskuläre Erkrankungen - nichtalkoholische
Fettlebererkrankung - maligne Erkrankungen
Keywords
obesity - metabolic syndrome - cardiovascular disease - non-alcoholic fatty liver
dise - cancer
